Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is tend to be around 7.80% in the mentioned forecast period.
Intravenous Immunoglobulin Market Analysis and Size
Immunoglobulin are manufactured from a huge pool of human plasma that is collected from at least 100 donors or more. The intramuscular route of administration is a conventional method and is not preferred currently, as it is painful. Intravenous immunoglobulin has developed as a boon in the last few years for patients with compromised immune systems. The increasing burden of target diseases such as primary immunodeficiency diseases is projected to boost the growth of the market.
Data Bridge Market Research analyses a growth rate in the intravenous immunoglobulin market in the forecast period 2023-2030. The expected CAGR of intravenous immunoglobulin market is tend to be around 7.80% in the mentioned forecast period. The market was valued at USD 11.97 million in 2022, and it would grow upto USD 21.83 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Immunoglobulin is the product breakdown of blood plasma that contains antibody. Immunoglobulin is a blood product which is generally administered through intravenous route. It consists of polyvalent IgG antibodies extracted from blood donors' plasma. Many patients are suffering from disorders such Wiskott Aldrich Syndrome, X-linked agammaglobulinemia who are unable to produce enough antibodies. Thus they benefit from intravenous immunoglobulin to maintain the sufficient level of antibodies in the body.
Comments
Post a Comment